ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,497, issued on Dec. 30, was assigned to Tectonic Operating Co. Inc. (Watertown, Mass.).

"Relaxin-2 fusion protein analogs and methods of using same" was invented by John Diener (Watertown, Mass.), Andrew Kruse (Watertown, Mass.) and Franz Gruswitz (Watertown, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides relaxin-2 fusion protein analogs with enhanced in vivo half-life and methods for making the same. Also disclosed herein are methods of treating relaxin-2-associated disorders or diseases using the relaxin-2 fusion protein analogs described herein."

The patent was filed on Nov. 11, 2022, under Application No. 1...